Healthcare Infection Control Practices Advisory Committee (HICPAC), 57947-57948 [E7-20045]
Download as PDF
<![CDATA[
57947
Federal Register / Vol. 72, No. 196 / Thursday, October 11, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) allow the renewal of the
generic information collection project:
‘‘Voluntary Customer Surveys Generic
Clearance for the Agency for Healthcare
Research and Quality’’ In accordance
with the Paperwork Reduction Act of
1995, Public Law 104–13 (44 U.S.C.
3506(c)(2)(A)), AHRQ invites the public
to comment on this proposed
information collection.
This proposed information collection
was previously published in the Federal
Register on August 3, 2007 and allowed
60 days for public comment. No
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment.
DATES: Comments on this notice must be
received by November 13, 2007.
ADDRESSES: Written comments should
be submitted to: AHRQ’s OMB Desk
Officer by fax at (202) 395–6974
(attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov
(attention: AHRQ’s desk officer).
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from AHRQ’s Report
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ, Reports
Clearance Officer, (301) 427–1477.
SUPPLEMENTARY INFORMATION:
Proposed Project
Voluntary Customer Surveys Generic
Clearance for the Agency for Healthcare
Research and Quality
In response to Executive Order 12862,
the Agency for Healthcare Research
Quality (AHRQ) plans to conduct
voluntary customer surveys to assess
strengths and weaknesses in agency
program services. Customer surveys to
be conducted by AHRQ may include
readership surveys from individuals
using AHRQ automated and electronic
technology databases to determine
satisfaction with the information
provided or surveys to assess effect of
the grants streamlining efforts. Results
of these surveys will be used in future
program planning initiatives and to
redirect resources and efforts, as
needed, to improve AHRQ program
services. The current clearance will
expire January 31, 2008. This is a
request for a generic approval from
OMB to conduct customer surveys over
the next three years.
Methods of Collection
The data will be collected using a
combination of methodologies
appropriate to each survey. These
methodologies include:
• Evaluation forms;
• Mail surveys;
• Focus groups;
• Automated and electronic
technology (e.g., e-mail, Web-based
surveys, instant fax, AHRQ Publications
Clearinghouse customer feedback) and,
• Telephone surveys.
Estimated Annual Respondent Burden
No. of
respondents
Type of survey
Average hour
burden response
Total hours of
burden
Mail/Telephone Surveys ............................................................................................
Automated/Web-based ..............................................................................................
Focus Groups ............................................................................................................
51,200
52,000
200
0.15
0.163
1.0
7,680
8,476
200
Totals ..................................................................................................................
103,400
NA
16,356
This information collection will not
impose a cost burden on the
respondents beyond that associated
with their time to provide the required
data. There will be no additional costs
for capital equipment, software,
computer services, etc.
Estimated Annual Costs to the Federal
Government
The mail and telephone surveys and
focus groups will in some cases be
carried out under contract. Assuming
the contract cost per survey is $50,000–
$100,000, and for each focus group is
$20,000, total contract costs could be
$720,000 per year.
rwilkins on PROD1PC63 with NOTICES
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
VerDate Aug<31>2005
16:09 Oct 10, 2007
Jkt 214001
AHRQ health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Dated: October 2, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–5009 Filed 10–10–07; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates:
9 a.m.–5 p.m., November 13, 2007.
9 a.m.–4 p.m., November 14, 2007.
Place: Department of Health and
Human Services Building, 395 East
E:\FR\FM\11OCN1.SGM
11OCN1
57948
Federal Register / Vol. 72, No. 196 / Thursday, October 11, 2007 / Notices
Street, SW., Suite 9100, Washington, DC
20201.
Status: Open to the public, limited
only by the space available.
Purpose: The Committee is charged
with providing advice and guidance to
the Secretary, the Assistant Secretary for
Health, the Director, CDC, and the
Director, National Center for
Preparedness, Detection, and Control of
Infectious Diseases (NCPDCID),
regarding (1) The practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related
events in settings where healthcare is
provided; and (3) periodic updating of
guidelines and other policy statements
regarding prevention of healthcareassociated infections and healthcarerelated conditions.
Matters To Be Discussed: Agenda
items will include: IT Standards
Update; White Paper Updates; and
Updates on the Disinfection and
Sterilization Guideline. Agenda items
are subject to change as priorities
dictate.
Contact Person for More Information:
Angela B. Scott, Committee
Management Specialist, HICPAC,
Division of Healthcare Quality
Promotion, NCPDCID, CDC, 1600
Clifton Road, NE., Mailstop A–45,
Atlanta, Georgia 30333. Telephone:
(404) 639–1526.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: October 4, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20045 Filed 10–10–07; 8:45 am]
BILLING CODE 4163–18–P
Institutional Review Boards—21 CFR
56.115 (OMB Control Number 0910–
0130)—Extension
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0241]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Institutional
Review Boards
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
Fax written comments on the
collection of information by November
13, 2007.
DATES:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
baguilar@omb.eop.gov. All comments
should be identified with the OMB
control number 0910–0130.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Karen L. Nelson, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4816.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
When reviewing clinical research
studies regulated by FDA, institutional
review boards (IRBs) are required to
create and maintain records describing
their operations, and make the records
available for FDA inspection when
requested. These records include:
Written procedures describing the
structure and membership of the IRB
and the methods that the IRB will use
in performing its functions; the research
protocols, informed consent documents,
progress reports, and reports of injuries
to subjects submitted by investigators to
the IRB; minutes of meetings showing
attendance, votes, and decisions made
by the IRB, the number of votes on each
decision for, against, and abstaining, the
basis for requiring changes in or
disapproving research; records of
continuing review activities; copies of
all correspondence between
investigators and the IRB; statement of
significant new findings provided to
subjects of the research; and a list of IRB
members by name, showing each
member’s earned degrees, representative
capacity, and experience in sufficient
detail to describe each member’s
contributions to the IRB’s deliberations,
and any employment relationship
between each member and the IRB’s
institution. This information is used by
FDA in conducting audit inspections of
IRBs to determine whether IRBs and
clinical investigators are providing
adequate protections to human subjects
participating in clinical research.
In the Federal Register of June 28,
2007 (72 FR 35492), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
21 CFR Section
No. of
Recordkeepers
56.115
Annual Frequency
per Recordkeeping
5,000
14.6
Total Annual
Records
Hours per
Record
73,000
100
Total
rwilkins on PROD1PC63 with NOTICES
1There
Total Hours
7,300,000
7,300,000
are no capital costs or operating and maintenance costs associated with this collection of information.
The recordkeeping requirement
burden is based on the following: The
burden for each of the paragraphs under
21 CFR 56.115 has been considered as
one estimated burden. FDA estimates
VerDate Aug<31>2005
16:09 Oct 10, 2007
Jkt 214001
that there are approximately 5,000 IRBs.
The IRBs meet an average of 14.6 times
annually. The agency estimates that
approximately 100 hours of person-time
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
per meeting are required to meet the
requirements of the regulation.
E:\FR\FM\11OCN1.SGM
11OCN1
]]>Agencies
[Federal Register Volume 72, Number 196 (Thursday, October 11, 2007)]
[Notices]
[Pages 57947-57948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20045]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Times and Dates:
9 a.m.-5 p.m., November 13, 2007.
9 a.m.-4 p.m., November 14, 2007.
Place: Department of Health and Human Services Building, 395 East
[[Page 57948]]
Street, SW., Suite 9100, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Preparedness,
Detection, and Control of Infectious Diseases (NCPDCID), regarding (1)
The practice of hospital infection control; (2) strategies for
surveillance, prevention, and control of infections (e.g., nosocomial
infections), antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of guidelines
and other policy statements regarding prevention of healthcare-
associated infections and healthcare-related conditions.
Matters To Be Discussed: Agenda items will include: IT Standards
Update; White Paper Updates; and Updates on the Disinfection and
Sterilization Guideline. Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Angela B. Scott, Committee
Management Specialist, HICPAC, Division of Healthcare Quality
Promotion, NCPDCID, CDC, 1600 Clifton Road, NE., Mailstop A-45,
Atlanta, Georgia 30333. Telephone: (404) 639-1526.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: October 4, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E7-20045 Filed 10-10-07; 8:45 am]
BILLING CODE 4163-18-P
